Early Start's new website

Head to http://www.cnn.com/shows/early-start for your news.




January 11th, 2013
07:33 AM ET

Flu outbreak worsens; National Institute of Allergy & Infectious Diseases Director Dr. Anthony Fauci explains

CNN is reporting brand new information on the rising flu influenza in the United States. Six more states are reporting widespread activity—that brings the total to 47 states, up from 41 the week before.

The Minnesota Health Department says 27 people have died from flu-related complications. South Carolina reports 22 flu-related deaths this season compared to one for all of 2011. Pennsylvania is also reporting 22 deaths, and six people are reported dead in Illinois. Eight are reported dead in Oklahoma, 15 are reported in Indiana, 7 in Arkansas and 18 flu related deaths in Massachusetts.

Dr. Anthony Fauci is the Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. He joins “Early Start” live from NIH headquarters in Bethesda, MD this morning with more on the nature of this outbreak.

Posted by
Filed under: Flu • Medical
soundoff (3 Responses)
  1. Tommie Orzechowski

    Shots might seem like an unusual way to treat allergies, but they're effective at decreasing sensitivity to triggers. The substances in the shots are chosen according to the allergens identified from a person's medical history and by the allergist during the initial testing. The U.S. Food and Drug Administration (FDA) oversees the standards used in preparing the materials for allergy shots given in the United States.

    June 7, 2013 at 5:08 am | Reply
  2. violet eason

    when reporting influenza cases, please report if the people with diagnosed influenza received the vaccination.

    January 13, 2013 at 8:25 am | Reply

Post a comment


CNN welcomes a lively and courteous discussion as long as you follow the Rules of Conduct set forth in our Terms of Service. Comments are not pre-screened before they post. You agree that anything you post may be used, along with your name and profile picture, in accordance with our Privacy Policy and the license you have granted pursuant to our Terms of Service.